Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Insights, Forecast to 2034
There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is expected to reach to US$ 389 million in 2024, with a positive growth of %, compared with US$ 363 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines industry is evaluated to reach US$ 696.7 million in 2029. The CAGR will be 10.2% during 2024 to 2029.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Covers
This report presents an overview of global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CAHIC
Boehringer Ingelheim
MSD Animal Health
Sino Pharm
Ceva
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tecon
Zoetis
WINSUN
PULILE
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Government Tender
Market Sales
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines plant distribution, commercial date of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines introduction, etc. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region
2.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024)
2.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2029)
2.2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
2.4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024)
2.4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029)
2.4.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers
3.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in 2022
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers
3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue in 2022
3.3 Global Key Players of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type
4.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type
4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type
4.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2018-2024)
4.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application
5.1.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application
5.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application
5.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2018-2024)
5.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
6.1.1 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
6.2.1 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
6.3.1 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
7.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2029)
7.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2029)
7.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
7.2.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2029)
7.2.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2029)
7.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Country
7.3.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
7.3.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size
8.1.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2018-2029)
8.1.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029)
8.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
8.2.1 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2029)
8.2.2 China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
9.1.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2029)
9.1.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2029)
9.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
9.2.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2029)
9.2.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2029)
9.3 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region
9.3.1 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CAHIC
11.1.1 CAHIC Company Information
11.1.2 CAHIC Overview
11.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CAHIC Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 MSD Animal Health
11.3.1 MSD Animal Health Company Information
11.3.2 MSD Animal Health Overview
11.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MSD Animal Health Recent Developments
11.4 Sino Pharm
11.4.1 Sino Pharm Company Information
11.4.2 Sino Pharm Overview
11.4.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sino Pharm Recent Developments
11.5 Ceva
11.5.1 Ceva Company Information
11.5.2 Ceva Overview
11.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ceva Recent Developments
11.6 ChengDu Tecbond
11.6.1 ChengDu Tecbond Company Information
11.6.2 ChengDu Tecbond Overview
11.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ChengDu Tecbond Recent Developments
11.7 Ringpu Biology
11.7.1 Ringpu Biology Company Information
11.7.2 Ringpu Biology Overview
11.7.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ringpu Biology Recent Developments
11.8 Qilu Animal
11.8.1 Qilu Animal Company Information
11.8.2 Qilu Animal Overview
11.8.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Qilu Animal Recent Developments
11.9 DHN
11.9.1 DHN Company Information
11.9.2 DHN Overview
11.9.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 DHN Recent Developments
11.10 CAVAC
11.10.1 CAVAC Company Information
11.10.2 CAVAC Overview
11.10.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CAVAC Recent Developments
11.11 Komipharm
11.11.1 Komipharm Company Information
11.11.2 Komipharm Overview
11.11.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Komipharm Recent Developments
11.12 Agrovet
11.12.1 Agrovet Company Information
11.12.2 Agrovet Overview
11.12.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Agrovet Recent Developments
11.13 Bioveta
11.13.1 Bioveta Company Information
11.13.2 Bioveta Overview
11.13.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bioveta Recent Developments
11.14 Jinyu Bio-Technology
11.14.1 Jinyu Bio-Technology Company Information
11.14.2 Jinyu Bio-Technology Overview
11.14.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Jinyu Bio-Technology Recent Developments
11.15 Phibro Animal Health
11.15.1 Phibro Animal Health Company Information
11.15.2 Phibro Animal Health Overview
11.15.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Phibro Animal Health Recent Developments
11.16 Tecon
11.16.1 Tecon Company Information
11.16.2 Tecon Overview
11.16.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Tecon Recent Developments
11.17 Zoetis
11.17.1 Zoetis Company Information
11.17.2 Zoetis Overview
11.17.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zoetis Recent Developments
11.18 WINSUN
11.18.1 WINSUN Company Information
11.18.2 WINSUN Overview
11.18.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 WINSUN Recent Developments
11.19 PULILE
11.19.1 PULILE Company Information
11.19.2 PULILE Overview
11.19.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 PULILE Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Chain Analysis
12.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production Mode & Process
12.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Marketing
12.4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Channels
12.4.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
12.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers
13 Market Dynamics
13.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
13.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
13.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
13.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
14 Key Findings in The Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (M Units)
Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (M Units)
Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Manufacturers (2018-2024) & (M Units)
Table 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Manufacturers (2018-2024)
Table 17. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Manufacturers 2018-2024 (USD/K Unit)
Table 21. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2022)
Table 23. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (M Units)
Table 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Type (2018-2024)
Table 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Type (2024-2029)
Table 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Type (2024-2029)
Table 35. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Type (2024-2029) & (USD/K Unit)
Table 37. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (M Units)
Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (M Units)
Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Application (2018-2024)
Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Application (2024-2029)
Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Application (2024-2029)
Table 45. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price Forecast by Application (2024-2029) & (USD/K Unit)
Table 47. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 48. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (M Units)
Table 49. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (M Units)
Table 52. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (M Units)
Table 53. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 59. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 60. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 61. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (M Units)
Table 62. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (M Units)
Table 65. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (M Units)
Table 66. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 72. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 73. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 74. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (M Units)
Table 75. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (M Units)
Table 78. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (M Units)
Table 79. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 82. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (M Units)
Table 83. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (M Units)
Table 86. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (M Units)
Table 87. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (M Units)
Table 93. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (M Units)
Table 94. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 95. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (M Units)
Table 99. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (M Units)
Table 100. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 106. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 107. CAHIC Company Information
Table 108. CAHIC Description and Major Businesses
Table 109. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CAHIC Recent Developments
Table 112. Boehringer Ingelheim Company Information
Table 113. Boehringer Ingelheim Description and Major Businesses
Table 114. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Boehringer Ingelheim Recent Developments
Table 117. MSD Animal Health Company Information
Table 118. MSD Animal Health Description and Major Businesses
Table 119. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. MSD Animal Health Recent Developments
Table 122. Sino Pharm Company Information
Table 123. Sino Pharm Description and Major Businesses
Table 124. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sino Pharm Recent Developments
Table 127. Ceva Company Information
Table 128. Ceva Description and Major Businesses
Table 129. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ceva Recent Developments
Table 132. ChengDu Tecbond Company Information
Table 133. ChengDu Tecbond Description and Major Businesses
Table 134. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. ChengDu Tecbond Recent Developments
Table 137. Ringpu Biology Company Information
Table 138. Ringpu Biology Description and Major Businesses
Table 139. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ringpu Biology Recent Developments
Table 142. Qilu Animal Company Information
Table 143. Qilu Animal Description and Major Businesses
Table 144. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Qilu Animal Recent Developments
Table 147. DHN Company Information
Table 148. DHN Description and Major Businesses
Table 149. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 150. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. DHN Recent Developments
Table 152. CAVAC Company Information
Table 153. CAVAC Description and Major Businesses
Table 154. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 155. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CAVAC Recent Developments
Table 157. Komipharm Company Information
Table 158. Komipharm Description and Major Businesses
Table 159. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 160. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Komipharm Recent Developments
Table 162. Agrovet Company Information
Table 163. Agrovet Description and Major Businesses
Table 164. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 165. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Agrovet Recent Developments
Table 167. Bioveta Company Information
Table 168. Bioveta Description and Major Businesses
Table 169. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 170. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Bioveta Recent Developments
Table 172. Jinyu Bio-Technology Company Information
Table 173. Jinyu Bio-Technology Description and Major Businesses
Table 174. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 175. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Jinyu Bio-Technology Recent Developments
Table 177. Phibro Animal Health Company Information
Table 178. Phibro Animal Health Description and Major Businesses
Table 179. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 180. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Phibro Animal Health Recent Developments
Table 182. Tecon Company Information
Table 183. Tecon Description and Major Businesses
Table 184. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 185. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Tecon Recent Developments
Table 187. Zoetis Company Information
Table 188. Zoetis Description and Major Businesses
Table 189. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 190. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Zoetis Recent Developments
Table 192. WINSUN Company Information
Table 193. WINSUN Description and Major Businesses
Table 194. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 195. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. WINSUN Recent Developments
Table 197. PULILE Company Information
Table 198. PULILE Description and Major Businesses
Table 199. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 200. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. PULILE Recent Developments
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List
Table 205. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Customers List
Table 206. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends
Table 207. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
Table 208. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
Table 209. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Picture
Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Application in 2022 & 2029
Figure 8. Government Tender
Figure 9. Market Sales
Figure 10. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Report Years Considered
Figure 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue 2018-2029 (US$ Million)
Figure 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Region (2018-2029)
Figure 15. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales 2018-2029 ((M Units)
Figure 16. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2018-2029) & (M Units)
Figure 18. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2018-2029) & (M Units)
Figure 20. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2018-2029) & (M Units)
Figure 22. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2018-2029) & (M Units)
Figure 24. Asia (excluding China) Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales YoY (2018-2029) & (M Units)
Figure 26. Middle East, Africa and Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in the World: Market Share by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue in 2022
Figure 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2029)
Figure 31. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2029)
Figure 32. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2029)
Figure 33. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country (2018-2029)
Figure 39. US & Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Country (2018-2029)
Figure 40. U.S. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2029)
Figure 43. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2029)
Figure 44. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2029)
Figure 45. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2029)
Figure 46. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Country (2018-2029)
Figure 47. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Country (2018-2029)
Figure 48. Germany Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 49. France Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 50. UK Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2029)
Figure 54. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2029)
Figure 55. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2029)
Figure 56. China Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2029)
Figure 57. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type (2018-2029)
Figure 58. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Type (2018-2029)
Figure 59. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application (2018-2029)
Figure 60. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Market Share by Application (2018-2029)
Figure 61. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Region (2018-2029)
Figure 62. Asia Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Region (2018-2029)
Figure 63. Japan Porcine Reproductive Respirat
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices